🇺🇸 FDA

Company profile · Sponsor

AN2

AN2 Therapeutics

ANTX · NYSE pharma MENLO PARK, CA, USA
Pipeline
6
Drugs
0
Patents
0

Quick answer

AN2 (ANTX) is a pharma company. headquartered in MENLO PARK, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ANTX
Exchange NYSE
Company type pharma
Headquarters MENLO PARK, CA, USA
SEC CIK 0001880438

Pipeline (6)

Search pipeline →

  1. Epetraborole

    AN2

    MAC Lung Disease

    phase 3 small molecule terminated

    1 trial

  2. Epetraborole

    AN2

    Mycobacterium Abscessus Infection

    phase 2 small molecule active

    1 trial

  3. AN2-502998

    AN2

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. Epetraborole

    AN2

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  5. Epetraborole

    AN2

    Renal Insufficiency

    phase 1 small molecule completed

    1 trial

  6. Epetraborole and matching placebo

    AN2

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is AN2?

AN2 (ANTX) is a pharma company. headquartered in MENLO PARK, CA, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does AN2 sponsor?

We track 6 ClinicalTrials.gov-linked programs for AN2, including Epetraborole and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does AN2 company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.